Chronic Lymphocytic Leukemia
Showing NaN - NaN of 22
Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (drug, other, biological)
Active, not recruiting
- Anemia
- +2 more
- Cyclophosphamide
- +6 more
-
Birmingham, Alabama
- +795 more
Jan 28, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Ublituximab, Umbralisib, Venetoclax)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ublituximab
- +2 more
-
Birmingham, Alabama
- +49 more
Jan 20, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Bendamustine, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Los Angeles, California
- +142 more
Jan 10, 2023
Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Kraków, Poland
- +10 more
Dec 2, 2022
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
-
Birmingham, Alabama
- +49 more
Sep 21, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Obinutuzumab
- +3 more
-
Birmingham, Alabama
- +484 more
Aug 24, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib (ACP-196)
- +3 more
-
Chandler, Arizona
- +156 more
Jun 2, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Little Rock, Arkansas
- +144 more
Dec 3, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Post-Chlorambucil Therapy Follow-up
- +4 more
-
Duarte, California
- +106 more
Aug 6, 2021
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in Canada, United States (Entospletinib
Terminated
- Chronic Lymphocytic Leukemia
- +4 more
- Entospletinib MM
- Entospletinib SDD
-
Birmingham, Alabama
- +47 more
Nov 2, 2020
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Bendamustine HCl, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Ibrutinib
- +3 more
-
Birmingham, Alabama
- +159 more
Feb 20, 2020
Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)
Terminated
- Chronic Lymphocytic Leukemia
-
Duarte, California
- +79 more
Aug 5, 2019
Collecting and Storing Malignant, Borderline Malignant
Completed
- Acute Undifferentiated Leukemia
- +13 more
- Cytology Specimen Collection Procedure
-
Birmingham, Alabama
- +191 more
Jul 17, 2018
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Duarte, California
- +107 more
Nov 27, 2017
Chronic Lymphocytic Leukemia Trial in Worldwide (Rituximab, Fludarabine Phosphate, Cyclophosphamide)
Chronic Lymphocytic Leukemia Trial in Worldwide (FCR + Lumiliximab, FCR)
Terminated
- Chronic Lymphocytic Leukemia
- FCR + Lumiliximab
- FCR
-
Scottsdale, Arizona
- +193 more
Sep 17, 2015
Chronic Lymphocytic Leukemia Trial in United States (Lumiliximab with FCR)
Completed
- Chronic Lymphocytic Leukemia
- Lumiliximab with FCR
-
Birmingham, Alabama
- +4 more
Sep 17, 2015
Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564
Completed
- Acute Myelogenous Leukemia
- +3 more
- BMS-936564 (Anti-CXCR4)
-
Birmingham, Alabama
- +10 more
Mar 5, 2015
